{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:55:28Z","timestamp":1790996128480,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.mycmed.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T11:04:20Z","timestamp":1564225460000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Insights on the anticandidal activity of non-antifungal drugs"],"prefix":"10.1016","volume":"29","author":[{"given":"D.C.","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ferreira-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2019.07.004_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a019778","article-title":"The Candida pathogenic species complex","volume":"4","author":"Turner","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0355","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0360","first-page":"1","article-title":"Candida infections and therapeutic strategies: Mechanisms of action for traditional and alternative agents","volume":"9","author":"Santos","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0365","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1128\/EC.00254-07","article-title":"Multidrug resistance in fungi","volume":"6","author":"Gulshan","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0370","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s12010-015-1527-0","article-title":"In Vitro Antifungal Activity and Probable Fungicidal Mechanism of Aqueous Extract of Barleria Grandiflora","volume":"175","author":"Jain","year":"2015","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0375","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1099\/jmm.0.063834-0","article-title":"A novel nerolidol-rich essential oil from Piper claussenianum modulates Candida albicans biofilm","volume":"63","author":"Curvelo","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0380","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/cbdd.12504","article-title":"Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents","volume":"86","author":"Abr\u00e3o","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","article-title":"Combination Treatment of Invasive Fungal Infections combination therapy in practice guidelines for treatment of fungal","volume":"18","author":"Mukherjee","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0390","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1099\/jmm.0.075507-0","article-title":"In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates","volume":"63","author":"Bedini","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0395","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/2049-632X.12068","article-title":"An oral vaccine against candidiasis generated by a yeast molecular display system","volume":"69","author":"Shibasaki","year":"2013","journal-title":"Pathog Dis"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0400","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1200\/JCO.2014.55.8437","article-title":"Risk of Incremental Toxicities and Associated Costs of New Anticancer Drugs: A Meta-Analysis","volume":"32","author":"Ocana","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0405","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2013.04.001","article-title":"Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex","volume":"76","author":"Wade","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0410","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4062\/biomolther.2015.029","article-title":"Preclinical pharmacokinetic evaluation of \u03b2-lapachone: Characteristics of oral bioavailability and first-pass metabolism in rats","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol Ther"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0415","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMp1410676","article-title":"The Future of Japan's Health System\u2013Sustaining Good Health with Equity at Low Cost","volume":"373","author":"Reich","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0420","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cbdd.12378","article-title":"Drug repurposing based on drug-drug interaction","volume":"85","author":"Zhou","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0425","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0430","first-page":"e135","article-title":"Antifungal Activity against Candida Species of the Selective Serotonin-Reuptake Inhibitor Sertraline","volume":"33","author":"Fuchs","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0435","first-page":"11","article-title":"Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro","volume":"35","author":"Ledochowski","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0440","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.micpath.2017.04.008","article-title":"In vitro anti- Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates","volume":"107","author":"de Moraes","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0445","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1128\/AAC.02623-13","article-title":"Anti-Candida activity of fluoxetine alone and combined with fluconazole: A synergistic action against fluconazole-resistant strains","volume":"58","author":"Oliveira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0450","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/AAC.03046-15","article-title":"The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence","volume":"60","author":"Zhang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0455","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.05706-11","article-title":"The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates","volume":"56","author":"Holmes","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0180990","article-title":"Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species","volume":"12","author":"Nagayoshi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0465","first-page":"63","article-title":"An assessment of the in vitro antimicrobial effects of two antiepileptic drugs - Sodium valproate and phenytoin. Antonie van Leeuwenhoek","volume":"83","author":"Esiobu","year":"2003","journal-title":"Int J Gen Mol Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.01956","article-title":"pH-dependant antifungal activity of valproic acid against the human fungal pathogen Candida albicans","volume":"8","author":"Chaillot","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0475","first-page":"307","article-title":"Antiepileptic Drugs Inhibit Growth","volume":"13","author":"Kathwate","year":"2015","journal-title":"Dimorphism, and Biofilm Mode of Growth in Human Pathogen Candida albicans. Assay Drug Dev Technol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0480","first-page":"1","article-title":"Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis","volume":"2018","author":"Liang","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.riam.2013.10.004","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: A proposal as a therapeutic target and as a study model","volume":"31","author":"Andrade-Pav\u00f3n","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","article-title":"Growth inhibition of Candida species and Aspergillus fumigatus by statins","volume":"262","author":"Macreadie","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0495","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1567-1364.2006.00194.x","article-title":"Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata","volume":"7","author":"Westermeyer","year":"2007","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0500","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1203\/PDR.0b013e3181bd5bf8","article-title":"Simvastatin inhibits candida albicans biofilm in vitro","volume":"66","author":"Liu","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0505","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0510","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652012000400003","article-title":"In vitro synergism of simvastatin and fluconazole against Candida species","volume":"54","author":"Vasconcelos J\u00fanior","year":"2012","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0515","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1007\/s00253-018-8959-8","article-title":"Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway","volume":"102","author":"Luo","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0520","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/dmd.118.082032","article-title":"Comparison of antifungal azole interactions with adult cytochrome P450 3A4 versus neonatal cytochrome P450 3A7","volume":"46","author":"Godamudunage","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0525","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1345\/aph.1C467","article-title":"Simvastatin-fluconazole causing rhabdomyolysis","volume":"37","author":"Shaukat","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13693786.2012.692490","article-title":"Candidemia outcomes not improved with statin use","volume":"51","author":"Welch","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0535","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1371\/journal.pone.0077317","article-title":"Effect of Statin Use on Outcomes of Adults with Candidemia","volume":"8","author":"Cuervo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0540","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijantimicag.2009.08.004","article-title":"Isolation, identification and susceptibility of Pyrenochaeta romeroi in a case of eumycetoma of the foot in the UK","volume":"34","author":"Cerar","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0545","first-page":"129","volume":"32","author":"Ikami","year":"2009","journal-title":"Effect of Propranolol on Hyphae Formation Signal in Candida albicans"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0550","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1567-1364.12150","article-title":"Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization","volume":"14","author":"Yu","year":"2014","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0555","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11046-014-9735-7","article-title":"The Calcium Channel Blocker Verapamil Inhibits Oxidative Stress Response in Candida albicans","volume":"177","author":"Li","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0560","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/AAC.00966-12","article-title":"Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole","volume":"57","author":"\u00c2ngelo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0565","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2012.10.009","article-title":"In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms","volume":"41","author":"Yu","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00976","article-title":"Raging the war against inflammation with natural products","volume":"9","author":"Attiq","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0575","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans","volume":"48","author":"Alem","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0580","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.micpath.2009.12.003","article-title":"The role of diclofenac sodium in the dimorphic transition in Candida albicans","volume":"48","author":"Rashki Ghalehnoo","year":"2010","journal-title":"Microb Pathog"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0585","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jis594","article-title":"The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against candida albicans biofilms","volume":"206","author":"Bink","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0590","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2016.01.026","article-title":"In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp","volume":"24","author":"Rosato","year":"2016","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0595","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/AAC.06082-11","article-title":"In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C.\u00a0parapsilosis","volume":"56","author":"Zhou","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0600","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jac\/dki264","article-title":"Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry","volume":"56","author":"Pina-Vaz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0605","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.05056-14","article-title":"Ibuprofen Potentiates the In Vivo Antifungal Activity of Fluconazole against Candida albicans Murine Infection","volume":"59","author":"Miranda","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0610","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0615","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/np980425n","article-title":"Synthetic analogues of irlbacholine: A novel antifungal plant metabolite isolated from Irlbachia alata","volume":"62","author":"Lu","year":"1999","journal-title":"J Nat Prod"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0620","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.50.2.414-421.2006","article-title":"Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis","volume":"50","author":"Sorrell","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0625","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/dks353","article-title":"Effect of alkylphospholipids on Candida albicans biofilm formation and maturation","volume":"68","author":"Vila","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0630","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1128\/AAC.01890-15","article-title":"In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis","volume":"59","author":"Vila","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0635","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijantimicag.2016.07.022","article-title":"Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells","volume":"48","author":"Vila","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0640","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0645","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.44.11.2932-2938.2000","article-title":"Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans","volume":"44","author":"Marchetti","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0650","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1099\/jmm.0.073478-0","article-title":"The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex","volume":"63","author":"Cordeiro","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0655","doi-asserted-by":"crossref","first-page":"e4999","DOI":"10.7717\/peerj.4999","article-title":"Synergistic and antagonistic effects of immunomodulatory drugs on the action of antifungals against Candida glabrata and Saccharomyces cerevisiae","volume":"6","author":"Tome","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-016-0728-1","article-title":"The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms","volume":"16","author":"Jia","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0665","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-827X(01)01002-3","article-title":"Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance","volume":"56","author":"Lee","year":"2001","journal-title":"Farmaco"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0670","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2958.2012.08140.x","article-title":"Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor","volume":"85","author":"Niimi","year":"2012","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0675","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease","volume":"106","author":"Cowen","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0045109","article-title":"Hsp90 Is Involved in Apoptosis of Candida albicans by Regulating the Calcineurin-Caspase Apoptotic Pathway","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0685","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11046-012-9612-1","article-title":"Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species","volume":"175","author":"Zhang","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2019.07.004_bib0690","first-page":"1","article-title":"Synergistic effects of geldanamycin with fluconazole are associated with reactive oxygen species in Candida tropicalis resistant to azoles and amphotericin B","volume":"5762","author":"Jia","year":"2019","journal-title":"Free Radic Res"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319300551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523319300551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:48Z","timestamp":1761110388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523319300551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1156523319300551"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2019.07.004","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights on the anticandidal activity of non-antifungal drugs","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}